retatrutide phase 2 trial dose escalation schedule Difference between tirzepatide and retatrutide: the complete comparison guide Triple hormone receptor agonist retatrutide

Li Q, Tuo X, Li B, Deng Z, Qiu Y, Xie H

Data from similar medications shows significant weight regain within 12-18 months of discontinuation

While not a formal contraindication in UK prescribing information, clinicians should exercise vigilance in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia

Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms

dNETs most frequently expressed the receptor (45% were positive), albeit typically at modest levels, while a smaller percentage of pNETs (13%) were GLP-1R positive, though typically strongly expressing when positive

If youve struggled with symptoms of dry mouth, read on to learn what causes it and what you can do to get your diabetes under control